These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 5309584)
1. Ellagic acid induced thromboelastographic changes in the normal individual and in several coagulopathies. Girolami A; Scarpa R Haematol Lat; 1969; 12(2):143-54. PubMed ID: 5309584 [No Abstract] [Full Text] [Related]
2. High incidence of vaproate-induced coagulation disorders in children receiving valproic acid: a prospective study. Koenig S; Gerstner T; Keller A; Teich M; Longin E; Dempfle CE Blood Coagul Fibrinolysis; 2008 Jul; 19(5):375-82. PubMed ID: 18600085 [TBL] [Abstract][Full Text] [Related]
3. [Molecular-biology findings on various blood clotting factors]. Fiedler H Folia Haematol Int Mag Klin Morphol Blutforsch; 1972; 98(2):121-39. PubMed ID: 4122840 [No Abstract] [Full Text] [Related]
5. [Coagulation factors and blood platelets. (Presence and location of factor VIII and of fibrinogen in normal human platelets and in patients with coagulation disorders, using an immunofluorescence technic)]. Fabris F; Betterle C; Casonato A; De Marco L; Girolami A Ric Clin Lab; 1979; 9(2 Suppl):51-63. PubMed ID: 395621 [No Abstract] [Full Text] [Related]
6. [Study of abnormal blood coagulation by means of thrombelastography]. Tsubokura T Rinsho Byori; 1971 Aug; 19(8):544-53. PubMed ID: 5107018 [No Abstract] [Full Text] [Related]
8. Valproate-associated coagulopathies are frequent and variable in children. Gerstner T; Teich M; Bell N; Longin E; Dempfle CE; Brand J; König S Epilepsia; 2006 Jul; 47(7):1136-43. PubMed ID: 16886976 [TBL] [Abstract][Full Text] [Related]
9. Low factor VIII levels are a risk factor for bleeding in patients with factor XI deficiency. Weiss HJ J Thromb Haemost; 2005 Jan; 3(1):181-2. PubMed ID: 15634287 [No Abstract] [Full Text] [Related]
11. [On the question of the reduced platelet factor 3 activity in v. Willebrand-Jürgens-syndrome]. Winckelmann G; Walther C Folia Haematol (Frankf); 1964 Oct; 9(2):119-30. PubMed ID: 5300139 [No Abstract] [Full Text] [Related]
12. The immunological properties of factor VIII. I. Studies on the inhibitory activity of specific antisera to human antihemophilic globulin. Uszyński L Thromb Diath Haemorrh; 1966 Dec; 16(3):558-73. PubMed ID: 5301276 [No Abstract] [Full Text] [Related]
13. [On the incomplete correction of the hemophilic hemocoagulative error on the part of conductor blood. Thromboelastographic observations]. GIACCA S; NEGRINI AC Arch Maragliano Patol Clin; 1959 Aug; 15():1071-80. PubMed ID: 13827794 [No Abstract] [Full Text] [Related]
14. Reduced tissue factor (thromboplastin) activity in von Willebrand's disease. Zacharski LR; Rosenstein R; Cornwell GG; Davis WM; McIntyre OR Am J Med; 1974 Jul; 57(1):102-7. PubMed ID: 4546024 [No Abstract] [Full Text] [Related]
20. [Treatment of the patient with a coagulation defect in oral and maxillofacial surgery. III. The management of patients in a hypocoagulative state because of a hemophilic-type primary pathology]. Chiarini L; Bertoldi C; Narni F Minerva Stomatol; 1997 Mar; 46(3):115-31. PubMed ID: 9173221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]